Home › Funds › Nan Fung Group Holdings Ltd › OCS
Nan Fung Group Holdings Ltd position in OCS
OCULIS HOLDING AG · Health Care
Nan Fung Group Holdings Ltd reported holding 300,565 shares of OCS (OCULIS HOLDING AG) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 1.90% of its reported portfolio and ranking #16 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nan Fung Group Holdings Ltd's OCS position evolved
Nan Fung Group Holdings Ltd first disclosed a stake in OCS in Q3 2023 at 606,684 shares (US$6.7M). The position peaked in Q4 2025 at 514,702 shares, worth US$10.3M. Across 13 filings, Nan Fung Group Holdings Ltd increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 300,565 shares valued at US$2.8M. Notable position changes include a 32% trim in Q1 2026 (shares fell 48% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 606.68K | $6.67M | New |
| Q4 2023 | 518.93K | $5.83M | Reduce |
| Q1 2024 | 436.38K | $5.26M | Reduce |
| Q2 2024 | 436.38K | $5.21M | Hold |
| Q3 2024 | 436.38K | $5.35M | Hold |
| Q4 2024 | 436.38K | $7.42M | Hold |
| Q1 2025 | 514.70K | $9.79M | Add |
| Q2 2025 | 514.70K | $9.99M | Hold |
| Q3 2025 | 514.70K | $9.05M | Hold |
| Q4 2025 | 514.70K | $10.28M | Hold |
| Q1 2026 | 350.75K | $9.33M | Reduce |
| Q2 2026 | 300.56K | $4.17M | Reduce |
| Q3 2026 | 300.56K | $2.81M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OCS and 13F data
OCS (OCULIS HOLDING AG) is a Health Care company. 66 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$15.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OCS
- EQT Fund Management S.a r.l. 6.95M sh · $64.92M · Q3 2026
- Gildi - lifeyrissjodur 2.43M sh · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.66M sh · $15.49M · Q3 2026
- Saturn V Capital Management LP 684.88K sh · $9.50M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 641.02K sh · $8.89M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K sh · $2.82M · Q3 2026
- Checkpoint Capital L.P. 99.50K sh · $929.33K · Q3 2026
- Marble Bar Asset Management LLP 14.81K sh · $205.36K · Q2 2026
- DUPONT CAPITAL MANAGEMENT CORP 4 sh · $37.00K · Q3 2026
More on Nan Fung Group Holdings Ltd
FAQ
How long has Nan Fung Group Holdings Ltd held OCS?
Nan Fung Group Holdings Ltd has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nan Fung Group Holdings Ltd's current position in OCS?
As of Q3 2026, Nan Fung Group Holdings Ltd holds 300.56K shares of OCS (OCULIS HOLDING AG), valued at $2.81M, representing 1.90% of its reported portfolio and ranking #16.
Has Nan Fung Group Holdings Ltd been buying or selling OCS?
In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in OCS. The position peaked in Q4 2025 at 514.70K shares.
Which other funds hold OCS?
Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.